Clinical Research & Medicines
Eye on the Experts: Regeneron Perspectives on Ophthalmology Innovation
April 24, 2025
Sharing our scientific approach and lessons learned as we look toward the future.
By: Regeneron Editorial
Vision-threatening conditions can severely impact independence and quality of life, affecting the ability to read, drive and even recognize loved ones. Since launching our first ophthalmology clinical development program in 2004, our groundbreaking science has helped transform the treatment of certain retinal diseases, including wet age-related macular degeneration, diabetic retinopathy, diabetic macular edema, macular edema following retinal vein occlusion and retinopathy of prematurity.
When diagnosed with these serious diseases twenty-five years ago, people often expected to face severe visual impairment or even blindness, but fortunately today, patients have options to help maintain or even restore their vision.
We’re proud of our pioneering advancements in ophthalmology and our collaborative approach to supporting the retinal community that has helped make a real difference for patients.
Today, we’re building on our leadership in angiogenesis by investigating ways to potentially address additional serious eye diseases. It is the collective expertise of individuals across this field — from our passionate leaders at Regeneron to the eye care professionals and organizations we collaborate with — that drives groundbreaking progress.
Sharing Insights from the Past to Inform the Future
We recognize that the field is always evolving with new-to-practice eye care professionals who may be familiar with our treatments, but not our deep-rooted history and approach to scientific innovation in this space. Our team’s extensive experience from two decades of research provides valuable insights for those with the shared mission of advancing care for patients with serious eye diseases. Our new series, Eye on the Experts, shares perspectives behind our approach to clinical innovation, featuring some of our leading ophthalmology experts.
Eye on the Experts covers topics intended to serve as helpful resources for the community, including new-to-practice retina specialists who are just beginning their professional journeys. Expect to hear:
- Reflections on Regeneron’s early days of research
- Background on how we design and execute clinical trials in ophthalmology, including incorporating patient input
- How we’re building on our legacy of innovation to continue driving meaningful change for patients
- Tips for maximizing professional experiences at medical congresses
How to Watch
Check out Eye on the Experts on YouTube. Be sure to subscribe and check back for more as new videos featuring additional experts will continue to be rolled out in the future.
Meet the Regeneron Experts
We’re proud to have extensive expertise among the many leaders helping us push the bounds of science. Meet some of the experts featured in the videos:
Alyson Berliner, MD, PhD, Executive Medical Director, Clinical Sciences, Regeneron Ophthalmology
“Regeneron's success and challenges throughout the past 20+ years in ophthalmology and beyond have made it possible to test new combinations of pipeline assets and potentially develop a game changer in diseases with unmet need.”
Hadi Moini, PhD, Senior Director, Medical Affairs, Regeneron Ophthalmology
“There are several exciting trends emerging in clinical trial design and execution, including advances in AI-driven tools that detect early signs of eye diseases, potentially improving outcomes if patients can be treated earlier in the course of their disease.”
Aditya (Ady) Athanikar, MD, Senior Medical Director, Clinical Sciences, Regeneron Ophthalmology
“Regeneron’s continuity throughout years of research, combined with our deep expertise and experience in real-world clinical settings, gives us a strong platform to drive this meaningful change for our patients.”
Rohini Rao, MD, Senior Medical Director, Clinical Sciences, Regeneron Ophthalmology
“For me, taking time to learn and connect with others in the field is always a great way to recharge and refocus. It’s a reminder of why I do what I do and an opportunity to gain new insights from experts, which I can bring back to my team. Experiences like these help us grow, strengthen our knowledge, and ultimately make a bigger impact for patients.”
Tavé van Zyl, MD, Senior Medical Director, Clinical Sciences, Regeneron Ophthalmology
“We are continuously assessing and innovating on how we design and conduct our clinical studies to improve patient’s experiences and outcomes. Remote data collection technologies, for example, have made a real impact by allowing us to gather real-time data from patients while they’re in the comfort of their own homes.”